Quotes 5-day view Delayed Nyse
01/30/2023
01/31/2023
02/01/2023
02/02/2023
02/03/2023
Date
145.76(c)
148.48(c)
148.64(c)
145.47(c)
142.81(c)
Last
719 609
1 136 008
1 520 052
3 043 014
1 316 045
Volume
+0.09%
+1.87%
+0.11%
-2.13%
-1.83%
Change
Estimated financial data (e) (USD)
Sales 2022
9 828 M
-
-
Net income 2022
1 054 M
-
-
Net Debt 2022
3 133 M
-
-
P/E ratio 2022
16,3x
Yield 2022
1,80%
Sales 2023
8 979 M
-
-
Net income 2023
875 M
-
-
Net Debt 2023
3 388 M
-
-
P/E ratio 2023
18,9x
Yield 2023
1,90%
Capitalization
16 264 M
16 264 M
-
EV / Sales 2022
1,97x
EV / Sales 2023
2,19x
Nbr of Employees
50 000
Free-Float
67,9%
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Ratings of Quest Diagnostics Incorporated
All news about QUEST DIAGNOSTICS INCORPORATED
02/03 Wells Fargo Adjusts Quest Diagnostics' Price Target to $140 From $135, Maintains Equal .. MT
02/02 Transcript : Quest Diagnostics Incorporated, Q4 2022 Earnings Call, Feb 02, 2.. CI
02/02 Quest Diagnostics' Q4 Adjusted Earnings, Revenue Fall; Raises Quarterly Dividend MT
02/02 Quest Diagnostics : Q4 Earnings Snapshot AQ
02/02 GUIDANCE: (DGX) QUEST DIAGNOSTICS Expects Fiscal Year 2023 Revenue Range $8.83B.. MT
02/02 GUIDANCE: (DGX) QUEST DIAGNOSTICS Sees Fiscal Year 2023 EPS Range $8.40 - $9.00 MT
02/02 Earnings Flash (DGX) QUEST DIAGNOSTICS Posts Q4 Revenue $2.33B, vs. Street Est of $2.26.. MT
02/02 Earnings Flash (DGX) QUEST DIAGNOSTICS Reports Q4 EPS $1.98, vs. Street Est of $1.90 MT
02/02 Quest Diagnostics Inc : Results of Operations and Financial Condition, Other Events, Finan.. AQ
02/02 Quest Diagnostics Incorporated Provides Earnings Guidance for the Full Year of 2023 CI
02/02 Tranche Update on Quest Diagnostics Incorporated (N.. CI
02/02 Quest diagnostics reports fourth quarter and full year 2022 financial results; provides.. PR
02/02 Quest Diagnostics Increases Dividend 7.6% To $0.71 Per Quarter; Announces $1 Billion In.. PR
02/02 Quest Diagnostics Incorporated Increases Dividend, Payable on April 24, 2023 CI
02/02 Quest Diagnostics Incorporated announces an Increase in Equity Buyback CI
News in other languages on QUEST DIAGNOSTICS INCORPORATED
Analyst Recommendations on QUEST DIAGNOSTICS INCORPORATED
ETFs positioned on QUEST DIAGNOSTICS INCORPORATED ETFs and Trackers with Trackinsight
Chart QUEST DIAGNOSTICS INCORPORATED
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends QUEST DIAGNOSTICS INCORPORATED
Short Term Mid-Term Long Term Trends Bearish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
142,81 $
Average target price
149,21 $
Spread / Average Target
4,48%
Please enable JavaScript in your browser's settings to use dynamic charts.